Advanced Therapies
Cell and gene therapies, collectively regulated as advanced therapies, are covered in this section, along with mRNA. We introduce the many advanced therapy formats and take you through the manufacturing, clinical development, and regulatory journey.
The most advanced, most complex, and most promising class of therapeutics has provided 20% new drug approvals between 2020 and mid-2026. Learn the basics of manufacturing each of these living therapies and how manufacturers are becoming integral in developing the therapeutic itself. Analytical technologies are developing rapidly to support increasing quality and regulatory standards. We’ve performed our own analysis of viral vector-based and RNA-based clinical trials to support our take on industry trends.
